← Leaderboards
Brock Clarke Christensen
Dartmouth College
$12,717,693
Attributed
$14,384,304
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,384,304 · 12
By mechanism
R01$8,995,471 · 3
P20$3,410,222 · 2
P30$1,597,640 · 6
R21$380,971 · 1
Top collaborators
- Karl T Kelsey5 shared
Most similar at Dartmouth College
Same institution · by research overlap
- John Anthony Baron$64,077,383
- Alexander Hartov$2,288,350
- William G North$5,028,670
- Raymond P Perez$3,553,952
- Steven D Leach$25,866,740
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularMalignant NeoplasmsBaseResourcesDna MethylationRisk FactorsProgramsTumorBloodSiteFundingBiologicalSamplingDesignPopulation StudyMemberResearch PersonnelEpigenetic ProcessImmuneMolecular EpidemiologyCellsFutureMethylationCancer Patient
Grant awards (36)
DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy$660,888
R01 · FY2025 · CA
Core B: Biorepository and Biospecimen Resource Facility Core$385,911
P30 · FY2025 · GM · contact PI
Cancer Population Sciences$78,889
P30 · FY2025 · CA · contact PI
DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy$631,543
R01 · FY2024 · CA
Core B: Biorepository and Biospecimen Resource Facility Core$377,952
P30 · FY2024 · GM · contact PI
Cancer Population Sciences (CPS)$72,343
P30 · FY2024 · CA · contact PI
Cancer Population Sciences (CPS)$5,263
P30 · FY2024 · CA · contact PI
DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy$649,712
R01 · FY2023 · CA
Core B: Biorepository and Biospecimen Resource Facility Core$394,223
P30 · FY2023 · GM · contact PI
Cancer Population Sciences (CPS)$72,344
P30 · FY2023 · CA · contact PI
DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy$650,458
R01 · FY2022 · CA
Core B: Biorepository Core$498,883
P20 · FY2022 · GM · contact PI
Cancer Population Sciences (CPS)$72,344
P30 · FY2022 · CA · contact PI
DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy$740,622
R01 · FY2021 · CA
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes$472,491
R01 · FY2021 · CA · contact PI
Core B: Biorepository Core$395,051
P20 · FY2021 · GM · contact PI
Cancer Population Sciences (CPS)$72,344
P30 · FY2021 · CA · contact PI
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes$613,106
R01 · FY2020 · CA · contact PI
Core B: Biorepository Core$450,814
P20 · FY2020 · GM · contact PI
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes$593,972
R01 · FY2019 · CA · contact PI
Core B: Biorepository Core$440,821
P20 · FY2019 · GM · contact PI
Cancer Epidemiology (CE)$66,027
P30 · FY2019 · CA · contact PI
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes$602,394
R01 · FY2018 · CA · contact PI
Core B: Biorepository Core$462,540
P20 · FY2018 · GM · contact PI
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes$632,860
R01 · FY2017 · CA · contact PI
Early Risk Factor Related Epigenetic Alterations in Breast Cancer Pathogenesis$243,040
P20 · FY2017 · GM · contact PI
MicroRNA related genetic variation and head and neck cancer$486,381
R01 · FY2016 · DE · contact PI
Early Risk Factor Related Epigenetic Alterations in Breast Cancer Pathogenesis$234,863
P20 · FY2016 · GM · contact PI
MicroRNA related genetic variation and head and neck cancer$757,809
R01 · FY2015 · DE · contact PI
Early Risk Factor Related Epigenetic Alterations in Breast Cancer Pathogenesis$234,865
P20 · FY2015 · GM · contact PI
MicroRNA related genetic variation and head and neck cancer$770,729
R01 · FY2014 · DE · contact PI
Early Risk Factor Related Epigenetic Alterations in Breast Cancer Pathogenesis$215,087
P20 · FY2014 · GM · contact PI
MicroRNA Related Genetic Variation in Bladder Cancer Recurrence and Survival$205,068
R21 · FY2014 · CA · contact PI
MicroRNA related genetic variation and head and neck cancer$732,506
R01 · FY2013 · DE · contact PI
Early Risk Factor Related Epigenetic Alterations in Breast Cancer Pathogenesis$234,258
P20 · FY2013 · GM · contact PI
MicroRNA Related Genetic Variation in Bladder Cancer Recurrence and Survival$175,903
R21 · FY2013 · CA · contact PI